Toshihiko Maruyama

489 total citations
7 papers, 388 citations indexed

About

Toshihiko Maruyama is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Toshihiko Maruyama has authored 7 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Biochemistry and 2 papers in Molecular Biology. Recurrent topics in Toshihiko Maruyama's work include Eicosanoids and Hypertension Pharmacology (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Adenosine and Purinergic Signaling (1 paper). Toshihiko Maruyama is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Adenosine and Purinergic Signaling (1 paper). Toshihiko Maruyama collaborates with scholars based in Japan, Qatar and Germany. Toshihiko Maruyama's co-authors include Yoshihiro Urade, Shigekazu Nagata, Hiroshi Yamaguchi, Kosuke Aritake, Nanae Nagata, Shinya Kamauchi, Tomoyoshi Nozaki, Bruno Kilunga Kubata, Kei Ohkubo and Craig Joe Munday and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Toshihiko Maruyama

7 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshihiko Maruyama Japan	7	165	105	92	61	57	7	388
Marta Ordoñez Spain	15	512 3.1×	83 0.8×	92 1.0×	29 0.5×	122 2.1×	18	717
Io-Guané Rivera Spain	11	461 2.8×	77 0.7×	58 0.6×	23 0.4×	101 1.8×	12	596
Pamela Kell United States	12	188 1.1×	53 0.5×	45 0.5×	28 0.5×	181 3.2×	19	474
Inmaculada Hernández Spain	14	271 1.6×	78 0.7×	27 0.3×	53 0.9×	45 0.8×	23	486
Giulio Morozzi Italy	6	284 1.7×	44 0.4×	258 2.8×	25 0.4×	86 1.5×	7	595
Cagla Akay United States	17	294 1.8×	101 1.0×	62 0.7×	46 0.8×	58 1.0×	33	718
Tuomas Ryhänen Finland	14	356 2.2×	47 0.4×	113 1.2×	57 0.9×	18 0.3×	19	629
J A Sandler United States	8	186 1.1×	192 1.8×	36 0.4×	19 0.3×	151 2.6×	11	528
Zhenyang Zhao United States	12	304 1.8×	55 0.5×	74 0.8×	71 1.2×	27 0.5×	22	627

Countries citing papers authored by Toshihiko Maruyama

Since Specialization

Citations

This map shows the geographic impact of Toshihiko Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Maruyama more than expected).

Fields of papers citing papers by Toshihiko Maruyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Maruyama. The network helps show where Toshihiko Maruyama may publish in the future.

Co-authorship network of co-authors of Toshihiko Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Maruyama. A scholar is included among the top collaborators of Toshihiko Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Maruyama. Toshihiko Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Yamaguchi, Hiroshi, Toshihiko Maruyama, Yoshihiro Urade, & Shigekazu Nagata. (2014). Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells. eLife. 3. e02172–e02172. 81 indexed citations

Murata, Takahisa, Kosuke Aritake, Yoshiki Tsubosaka, et al.. (2013). Anti-inflammatory role of PGD ₂ in acute lung inflammation and therapeutic application of its signal enhancement. Proceedings of the National Academy of Sciences. 110(13). 5205–5210. 80 indexed citations

Fujimori, Ko, Toshihiko Maruyama, Shinya Kamauchi, & Yoshihiro Urade. (2012). Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ12-PGJ2 acting through PPARγ-dependent and independent pathways. Gene. 505(1). 46–52. 23 indexed citations

Shinozawa, Takao, et al.. (2011). Tetranor PGDM analyses for the amyotrophic lateral sclerosis: Positive and simple diagnosis and evaluation of drug effect. Biochemical and Biophysical Research Communications. 415(4). 539–544. 8 indexed citations

Mohri, Ikuko, Kosuke Aritake, Hidetoshi Taniguchi, et al.. (2009). Inhibition of Prostaglandin D Synthase Suppresses Muscular Necrosis. American Journal Of Pathology. 174(5). 1735–1744. 43 indexed citations

Irikura, Daisuke, et al.. (2009). Biochemical, Functional, and Pharmacological Characterization of AT-56, an Orally Active and Selective Inhibitor of Lipocalin-type Prostaglandin D Synthase. Journal of Biological Chemistry. 284(12). 7623–7630. 40 indexed citations

Kubata, Bruno Kilunga, Zakayi Kabututu, Tomoyoshi Nozaki, et al.. (2002). A Key Role for Old Yellow Enzyme in the Metabolism of Drugs by Trypanosoma cruzi . The Journal of Experimental Medicine. 196(9). 1241–1252. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact